New Products In Brief
This article was originally published in The Gray Sheet
Abbott’s Absolute Pro iliac stent and Enzo Biochem’s ColonSentry colorectal cancer test are among newly approved devices.
You may also be interested in...
Recent approvals and launches include Abbott’s Omnilink Elite balloon expandable vascular stent for iliac artery disease and J&J/Codman’s Medstream implantable infusion pump for spasticity.
The field of women's health is one of the most progressive medical technology sectors in the US, driven by the aging population, diagnostic advances in deadly ovarian and colorectal cancer, and medical device innovations in gynecologic and urogynecologic disease management, including a shift toward minimally invasive surgery (MIS) techniques and robotics and the addition of a new field: bariatric gynecology. At the WH 2.0 Consensus Conference on Women's Health, held recently in Los Angeles, experts agreed that advances in medical technology are promising better detection and treatment of a host of diseases impacting both premenopausal and postmenopausal women. However, challenges remain in managing obesity-related disease and improving screening for often-undetected cancers in women.
Hospira’s Symbiq 3.13 infusion pump and Organogenesis’ Gintuit oral soft tissue regeneration product are new on the market.